Skip to Content

Schizophrenia Tied to Increased Risk for Later Parkinson Disease

MONDAY, Feb. 1, 2021 -- Schizophrenia spectrum disorder increases the risk for Parkinson disease (PD) later in life, according to a study published online Jan. 6 in Movement Disorders.

Tomi Kuusimäki, M.D., from Turku University Hospital in Finland, and colleagues investigated the risk for PD after a diagnosis of a schizophrenia spectrum disorder. The analysis included 3,045 patients with a confirmed PD diagnosis (2004 to 2019).

The researchers found that the prevalence of earlier schizophrenia spectrum disorder was 0.76 percent in PD patients in regional data and 1.50 percent in nationwide data, while in age-matched controls, the prevalence of schizophrenia spectrum disorder in the regional and national data was 0.16 and 1.31 percent, respectively. Following a schizophrenia diagnosis, the odds ratio for PD was 4.63 in the regional data and 1.17 in the national data.

"The occurrence of PD and schizophrenia in the same person has been considered rare because these diseases are associated with opposite alterations in the brain's dopamine system," Kuusimäki said in a statement. "Our study changes this prevailing conception."

Abstract/Full Text

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Certain Prostate Drugs Tied to Risk for Parkinson Disease

THURSDAY, Feb. 18, 2021 -- Users of terazosin, doxazosin, or alfuzosin are at lower risk for developing Parkinson disease (PD) compared with users of tamsulosin, according to a...

ED Visit Volume Dropped for Mental Health, Substance Use Early in Pandemic

WEDNESDAY, Feb. 17, 2021 -- Emergency department visits for mental health, substance use, and violence decreased in the early days of the COVID-19 pandemic, according to a study...

Telehealth Use Up Markedly Among Parkinson Patients

WEDNESDAY, Feb. 10, 2021 -- Parkinson disease (PD) symptoms and management practices were markedly affected by COVID-19, according to a study published online Jan. 21 in npj...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.